Blood Sugar Regulation
FSH receptors on pancreatic cells suggest involvement in insulin regulation; low FSH associates with diabetes risk markers in postmenopausal women.[Cheng, 2023][Wang, 2016]
Follicle-stimulating hormone (FSH)
What is Follicle-stimulating hormone (FSH)?
Follicle-stimulating hormone (FSH) is a critical reproductive hormone produced by the pituitary gland that plays essential roles in fertility and sexual development. In women, FSH stimulates the growth of ovarian follicles, which contain eggs, and promotes estrogen production. In men, FSH works to support sperm production by stimulating Sertoli cells in the testes. FSH levels naturally fluctuate during the menstrual cycle in women and remain relatively stable in men.
Low FSH levels can indicate issues with the pituitary gland or hypothalamus, leading to irregular periods, infertility, or delayed puberty in women and reduced sperm counts in men. Chronically low FSH—especially alongside other hormonal imbalances—may signal the need for further evaluation.[Rothman, 2008]
High FSH levels often indicate reproductive aging: normal in menopause/perimenopause, but outside those phases may suggest primary gonadal failure. Elevated FSH has also been linked directly to bone loss.[Sun, 2006]
- Support overall endocrine health through balanced nutrition and activity
- Manage stress
- Maintain healthy body composition
- Ensure adequate vitamin D
- Moderate lifestyle factors like smoking and alcohol
Measurement Units
Follicle-stimulating hormone (FSH) can be measured in: U/L, µIU/mL, mIU/mL, IU/L
Reference Ranges by Age and Gender
Reference ranges represent typical values for healthy individuals. Your healthcare provider must interpret your specific results.
| Age Range | Gender | Unit | Optimal | Normal | Source |
|---|---|---|---|---|---|
| All ages | Woman | IU/L | - | 0.2 - 100.6 | Rifai, 2018 |
| All ages | Man | IU/L | - | 1.4 - 15.4 | Rifai, 2018 |
Health Impact
Inflammation
Studies have found associations between FSH levels and inflammatory markers in certain populations.[Cannon, 2010]
Premium
3 More Health Topics Available
Explore 3 additional health topics related to this biomarker in the Health3 app.
Related Biomarkers
-
Free TestosteroneIn men, FSH acts on Sertoli cells to support sperm development, while LH-driven testosterone completes maturation. Proper sperm production requires both hormones working in concert.[Iliadou, 2015]
-
Total TestosteroneIn men, FSH acts on Sertoli cells to support sperm development, while LH-driven testosterone completes maturation. Proper sperm production requires both hormones working in concert.[Iliadou, 2015]
-
Estradiol (Coming Soon)In women, estrogen and FSH form a crucial feedback loop - as FSH stimulates estrogen production, rising estrogen levels then suppress FSH release from the pituitary.[Coss, 2018] In men, estrogen (converted from testosterone) also provides negative feedback on FSH release, with imbalances potentially affecting reproductive function.
Academic References
- Rifai N.. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (6th ed.) (2018). Elsevier. View Source
- Cannon JG. FSH, interleukin-1, and bone density in adult women. (2010). Am J Physiol Regul Integr Comp Physiol. View Source
- Bi X. FSHR ablation induces depression-like behaviors. (2020). Acta Pharmacologica Sinica. View Source
- Coss D. Regulation of reproduction via gonadotropin hormone control. (2018). Molecular and Cellular Endocrinology. View Source
- Cheng Y. FSH orchestrates glucose-stimulated insulin secretion of pancreatic islets. (2023). Nature Communications. View Source
- Iliadou PK. The Sertoli cell: novel clinical potentiality. (2015). Hormones. View Source
- Sun L. FSH directly regulates bone mass. (2006). Cell. View Source
- Colaianni G. FSH and TSH in the pituitary/immune/bone axis. (2010). Journal of Immunology Research. View Source
- Rothman MS. Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis. (2008). Pituitary. View Source
- Cannon JG. FSH, interleukin-1, and bone density in adult women. (2010). Am J Physiol Regul Integr Comp Physiol. View Source
- Spicer J. Follicle-stimulating hormone: More than a marker for menopause; a frontier for women's mental health. (2025). Psychiatry Research. View Source
- Sun L. FSH directly regulates bone mass. (2006). Cell. View Source
- Wang N. FSH associates with prediabetes and diabetes in postmenopausal women. (2016). Acta Diabetologica. View Source
- Crawford ED. Potential role of FSH in cardiovascular, metabolic, skeletal & cognitive effects. (2017). Urologic Oncology. View Source
What FSH Measures and Why It Matters
Follicle-stimulating hormone (FSH) is a glycoprotein gonadotropin secreted by the anterior pituitary gland in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. Its primary roles differ by sex: in women, FSH drives the growth and maturation of ovarian follicles each menstrual cycle and stimulates estrogen production. In men, FSH acts on Sertoli cells in the testes to support spermatogenesis. FSH is part of the hypothalamic–pituitary–gonadal (HPG) axis — a finely tuned feedback loop in which sex hormones (estrogen, inhibin B, testosterone) regulate FSH secretion from the pituitary.
Because FSH sits at the top of the reproductive hormone cascade, it is a key marker for evaluating fertility, menstrual irregularity, early menopause, and male hypogonadism. An FSH blood test is typically ordered in combination with total testosterone, free testosterone, estradiol, and LH. See the Hormonal Balance topic page for related markers and the understanding hormones blood test guide.
FSH Reference Ranges by Life Stage
FSH ranges vary considerably by sex, reproductive phase, and age. The table below shows commonly cited thresholds from the Tietz Textbook and clinical references (Rifai, 2018). Always interpret against your laboratory's own reference interval, as methods and assays differ.
Source: Tietz Textbook of Clinical Chemistry (Rifai, 2018). Ranges vary by laboratory and assay method.
What High FSH Means
Elevated FSH reflects the pituitary working harder to stimulate gonads that are responding less — a pattern called primary gonadal failure. Common causes by population:
- Women (reproductive age): Premature ovarian insufficiency (POI), also called premature ovarian failure — FSH persistently >25 IU/L before age 40. Diminished ovarian reserve (DOR) in women seeking fertility treatment is often first identified by elevated Day 3 FSH (typically >10–12 IU/L)
- Women (perimenopause/menopause): Rising, fluctuating FSH >10 IU/L with cycle irregularity signals perimenopause. FSH ≥25 IU/L confirmed on two tests confirms menopause
- Men: Elevated FSH alongside low testosterone indicates primary hypogonadism (testicular origin), e.g., Klinefelter syndrome, orchitis, prior chemotherapy/radiation
- Both sexes: Turner syndrome, certain genetic conditions, and gonadal radiation damage
Research has also linked high FSH levels to bone loss — studies suggest FSH may directly stimulate osteoclast activity independent of estrogen decline (Sun et al., Cell, 2006), making FSH a potential cardiovascular and skeletal risk marker. See the Bone Health page.
What Low FSH Means
Low FSH alongside low sex hormones typically points to secondary (central) hypogonadism — the pituitary or hypothalamus is not sending adequate signals to the gonads. Causes include:
- Pituitary tumour (prolactinoma) or other pituitary disease
- Hypothalamic amenorrhoea (functional — due to extreme exercise, low body weight, or psychological stress)
- Exogenous anabolic steroid use (suppresses the HPG axis)
- Kallmann syndrome (genetic GnRH deficiency)
- Severe systemic illness, significant weight loss, or excessive exercise
In women, low FSH results in anovulation, irregular or absent periods, and reduced estrogen. In men, low FSH contributes to impaired sperm production.
Tracking FSH Over Time
For women approaching perimenopause, FSH fluctuates significantly from cycle to cycle. A single elevated reading does not confirm menopause — most guidelines (including NICE UK) require FSH ≥25 IU/L on two blood tests taken at least 6 weeks apart to confirm menopause in women under 50. Tracking FSH over multiple cycles gives a clearer picture of reproductive status than any single reading.
For men or women on hormone therapy, FSH monitoring helps assess suppression and response. Health3 supports longitudinal tracking so you can review trends across visits.
Related Markers to Test Alongside FSH
- LH (Luteinising Hormone) — works with FSH; the FSH:LH ratio helps differentiate PCOS (often low ratio) from premature ovarian failure (high ratio)
- Total Testosterone / Free Testosterone — low testosterone with high FSH suggests primary hypogonadism in men
- Estradiol (E2) — low estradiol with high FSH in women confirms ovarian failure
- Anti-Müllerian Hormone (AMH) — better marker of ovarian reserve than FSH; less cycle-dependent
- Prolactin — elevated prolactin suppresses GnRH and causes low FSH/LH
- DHEAS — adrenal androgen; relevant when evaluating androgen excess or PCOS
Frequently Asked Questions About FSH
What is a normal FSH level for women?
Normal FSH depends heavily on which phase of the menstrual cycle the blood was drawn. Day 3 FSH (early follicular phase) is most commonly used for fertility evaluation, with levels of 3–10 IU/L considered normal. Values above 10–12 IU/L on Day 3 may suggest diminished ovarian reserve. Postmenopausal FSH is typically >25–30 IU/L.
What FSH level confirms menopause?
A common clinical threshold is FSH ≥25 IU/L confirmed on two tests taken at least 4–6 weeks apart, combined with absent periods for 12 months (in women over 45). In women under 45 with symptoms, testing is especially important to rule out premature ovarian insufficiency. FSH alone is not sufficient — context, symptoms, and other hormones (LH, estradiol) matter.
What is a normal FSH level for men?
Most laboratories report a normal adult male range of approximately 1.4–15.4 IU/L. FSH in men is relatively stable (unlike the cyclical pattern in women). Elevated FSH in men most commonly indicates primary testicular failure (the testes are damaged or absent). Low FSH in men with low testosterone suggests pituitary or hypothalamic disease.
Can FSH levels predict fertility?
In women, elevated Day 3 FSH is one marker of reduced ovarian reserve, but it is not a definitive predictor of infertility. Anti-Müllerian Hormone (AMH) and antral follicle count are considered more reliable markers. A single FSH reading has limited predictive value; FSH should be interpreted alongside the full hormone panel and clinical symptoms.
When should FSH be tested during the menstrual cycle?
For fertility evaluation, FSH is typically measured on Day 2, 3, or 4 of the menstrual cycle (Day 1 = first day of menstruation). This early follicular phase measurement gives the baseline pituitary signal before it is suppressed by rising estrogen. Testing at other cycle phases can give misleading results.
Does high FSH mean I cannot get pregnant?
Not necessarily. Elevated FSH (particularly in the 10–20 IU/L range on Day 3) is associated with reduced ovarian reserve and can affect the response to fertility treatment, but pregnancy is still possible. FSH must be interpreted alongside other markers (AMH, antral follicle count, estradiol) and clinical context. A reproductive endocrinologist should evaluate this result in the context of your full fertility workup.
What is the link between FSH and bone health?
Research (Sun et al., Cell, 2006) suggests that FSH may directly stimulate bone resorption by activating FSH receptors on osteoclasts, contributing to bone loss during the menopausal transition independently of estrogen decline. This is an area of active investigation. People with persistently elevated FSH may benefit from bone health monitoring including bone density scans and relevant markers like calcium and vitamin D.
Medical Disclaimer
This page is for educational purposes only. FSH reference ranges vary significantly by laboratory, assay method, and phase of the menstrual cycle. A single result cannot diagnose any condition. Always review FSH results with a qualified healthcare provider — ideally alongside LH, estradiol, and other relevant hormones. Health3 is a tracking and awareness tool, not a diagnostic service.
Save this biomarker reference for your medical appointments
Was this information helpful?
Track Follicle-stimulating hormone (FSH) in Health3
Monitor your biomarkers, visualize trends, and share insights with your care team.